Search hospitals > Pennsylvania > Philadelphia
Abramson Cancer Center of the University of Pennsylvania
Claim this profilePhiladelphia, Pennsylvania 19104
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Leukemia
947 reported clinical trials
71 medical researchers
Summary
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 634 conditions. There are 71 research doctors associated with this hospital, such as Arati Desai, MD, Amy Clark, Lainie P. Martin, and Thomas Karasic, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Arati Desai, MDAbrams Cancer Center of the University of Pennsylvania5 years of reported clinical research
Studies Glioblastoma
Studies Brain Tumor
10 reported clinical trials
21 drugs studied
Amy ClarkUniversity of Pennsylvania1 year of reported clinical research
Studies Breast Cancer
Studies Tumors
10 reported clinical trials
29 drugs studied
Lainie P. MartinUniversity of Pennsylvania4 years of reported clinical research
Studies Ovarian Cancer
Studies Ovarian Tumors
9 reported clinical trials
18 drugs studied
Thomas Karasic, MDUniversity of Pennsylvania3 years of reported clinical research
Studies Cancer
Studies Colorectal Cancer
9 reported clinical trials
17 drugs studied
Clinical Trials running at Abramson Cancer Center of the University of Pennsylvania
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Esophageal Carcinoma
Cancer
Lung Cancer
Tumors
Non-Small Cell Lung Cancer
Pancreatic Cancer
Ovarian Cancer
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
This trial is testing a drug called sacituzumab govitecan-hziy, which targets and kills cancer cells. It focuses on patients with advanced triple-negative breast cancer who have limited treatment options. The drug works by attaching to cancer cells and releasing a substance that kills them. Sacituzumab govitecan-hziy is an FDA-approved treatment for metastatic triple-negative breast cancer, especially for patients who have already tried other treatments.
Recruiting4 awards Phase 3
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Abramson Cancer Center of the University of Pennsylvania?
Abramson Cancer Center of the University of Pennsylvania is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Leukemia and other specialties. Abramson Cancer Center of the University of Pennsylvania is involved with conducting 947 clinical trials across 634 conditions. There are 71 research doctors associated with this hospital, such as Arati Desai, MD, Amy Clark, Lainie P. Martin, and Thomas Karasic, MD.
Where is Abramson Cancer Center of the University of Pennsylvania located?
**Directions to Abramson Cancer Center, University of Pennsylvania, Philadelphia:**
- Take I-76 East to Exit 346B, University Avenue.
- Turn right onto Civic Center Boulevard.
- For real-time driving directions based on current traffic, consider using Waze.
Who should I call to ask about financial aid or insurance network?
**Abramson Cancer Center of the University of Pennsylvania - Financial and Insurance Assistance**
- **Financial Counseling Assistance:** Contact Tonya Boyer via email at Tonya.Boyer@pennmedicine.upenn.edu or by phone at 610-738-2510.
- **Insurance-Related Inquiries:** Reach out to Penn Medicine's customer service at 800-406-1177.
- **General Questions about Navigating Cancer Care:** Call 800-789-7366 (PENN).
What insurance does Abramson Cancer Center of the University of Pennsylvania accept?
The Abramson Cancer Center of the University of Pennsylvania accepts most major insurance plans. Patients are advised to confirm their insurance coverage with their provider before receiving care. Penn Medicine, including the Abramson Cancer Center, offers comprehensive care under various health plans, covering cancer and heart conditions.
What awards or recognition has Abramson Cancer Center of the University of Pennsylvania received?
The Abramson Cancer Center at the University of Pennsylvania is renowned for its exceptional cancer care, earning accolades from the Commission on Cancer (CoC). In 2023, four of its researchers were distinguished with prestigious awards from the American Association for Cancer Research (AACR).